152 related articles for article (PubMed ID: 26448446)
1. PROSE Treatment for Ocular Chronic Graft-Versus-Host Disease as a Clinical Network Expands.
DeLoss KS; Le HG; Gire A; Chiu GB; Jacobs DS; Carrasquillo KG
Eye Contact Lens; 2016 Jul; 42(4):262-6. PubMed ID: 26448446
[TBL] [Abstract][Full Text] [Related]
2. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.
Saboo US; Amparo F; Abud TB; Schaumberg DA; Dana R
Ophthalmology; 2015 Aug; 122(8):1669-74. PubMed ID: 26001816
[TBL] [Abstract][Full Text] [Related]
3. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Papakostas TD; Le HG; Chodosh J; Jacobs DS
Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
[TBL] [Abstract][Full Text] [Related]
4. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease.
Theophanous C; Irvine JA; Parker P; Chiu GB
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2180-2184. PubMed ID: 26234721
[TBL] [Abstract][Full Text] [Related]
5. Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy.
Chahal JS; Heur M; Chiu GB
Eye Contact Lens; 2017 Jul; 43(4):240-244. PubMed ID: 27171131
[TBL] [Abstract][Full Text] [Related]
6. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease.
Jacobs DS; Rosenthal P
Cornea; 2007 Dec; 26(10):1195-9. PubMed ID: 18043175
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
Zallio F; Mazzucco L; Monaco F; Astori MR; Passera R; Drago G; Tamiazzo S; Rapetti M; Dolcino D; Guaschino R; Pini M; Ladetto M
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and handling experience with the PROSE device: an Indian scenario.
Bhattacharya P; Mahadevan R
Clin Exp Optom; 2017 Nov; 100(6):710-717. PubMed ID: 28295635
[TBL] [Abstract][Full Text] [Related]
9. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
Russo PA; Bouchard CS; Galasso JM
Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
[TBL] [Abstract][Full Text] [Related]
10. Functional and visual improvement with prosthetic replacement of the ocular surface ecosystem scleral lenses for irregular corneas.
Lee JC; Chiu GB; Bach D; Bababeygy SR; Irvine J; Heur M
Cornea; 2013 Dec; 32(12):1540-3. PubMed ID: 24145631
[TBL] [Abstract][Full Text] [Related]
11. Prosthetic replacement of the ocular surface ecosystem: impact at 5 years.
Agranat JS; Kitos NR; Jacobs DS
Br J Ophthalmol; 2016 Sep; 100(9):1171-5. PubMed ID: 26644423
[TBL] [Abstract][Full Text] [Related]
12. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.
Yin J; Jacobs DS
Ocul Surf; 2019 Jan; 17(1):134-141. PubMed ID: 30468876
[TBL] [Abstract][Full Text] [Related]
14. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment for Complications After LASIK.
Mian SZ; Agranat JS; Jacobs DS
Eye Contact Lens; 2016 Nov; 42(6):371-373. PubMed ID: 27466722
[TBL] [Abstract][Full Text] [Related]
15. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
16. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome.
Le Q; Ge L; Li M; Wu L; Xu J; Hong J; Gong L
Acta Ophthalmol; 2014 Mar; 92(2):e124-32. PubMed ID: 23901943
[TBL] [Abstract][Full Text] [Related]
17. Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion: Results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials.
Varma R; Haller JA; Kaiser PK
JAMA Ophthalmol; 2015 Sep; 133(9):997-1004. PubMed ID: 26068086
[TBL] [Abstract][Full Text] [Related]
18. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome.
Heur M; Bach D; Theophanous C; Chiu GB
Am J Ophthalmol; 2014 Jul; 158(1):49-54. PubMed ID: 24699156
[TBL] [Abstract][Full Text] [Related]
19. PROSE Treatment in Atypical Ocular Graft-Versus-Host Disease.
Chiu GB; Theophanous C; Irvine JA
Optom Vis Sci; 2016 Nov; 93(11):1444-1448. PubMed ID: 27741087
[TBL] [Abstract][Full Text] [Related]
20. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos.
Baker RS; Bazargan M; Calderón JL; Hays RD
Ophthalmology; 2006 Aug; 113(8):1363-71. PubMed ID: 16877075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
